Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period.

Abstract:

BACKGROUND:Natural killer (NK) cell dysfunction following cancer surgery has been shown to promote metastases. Recent studies demonstrate an emerging role for lipids in the modulation of NK cell innate responses. However, the mechanisms involved in lipid modulation of NK cell postoperative anti-tumor function are unknown. This current study will determine whether the lipid accumulation via scavenger receptors on NK cells is responsible for the increase in postoperative metastasis. METHODS:Lipid content in mouse and human NK cells was evaluated by flow cytometry. NK cell scavenger receptor (SR) expression was measured by microarray analysis, validated by qRT-PCR and flow cytometry. NK cell ex vivo and in vivo tumor killing was measured by chromium-release and adoptive transfer assays, respectively. The mediating role of surgery-expanded granulocytic myeloid derived suppressor cells (gMDSC) in SR induction on NK cells was evaluated using co-culture assays. RESULTS:NK cells in surgery-treated mice demonstrated increased lipid accumulation, which occurred via up-regulation of MSR1, CD36 and CD68. NK cells with high lipid content had diminished ability to lyse tumor targets ex vivo. Adoptive transfer of lipid-laden NK cells into NK cell-deficient mice were unable to protect against a lung tumor challenge. Granulocytic MDSC from surgery-treated mice increased SR expression on NK cells. Colorectal cancer surgical patients showed increased NK cell lipid content, higher CD36 expression, decreased granzyme B and perforin production in addition to reduced cytotoxicity in the postoperative period. CONCLUSIONS:Postoperative lipid accumulation promotes the formation of metastases by impairing NK cell function in both preclinical surgical models and human surgical colorectal cancer patient samples. Understanding and targeting the mechanisms underlying lipid accumulation in innate immune NK cells can improve prognosis in cancer surgical patients.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Niavarani SR,Lawson C,Bakos O,Boudaud M,Batenchuk C,Rouleau S,Tai LH

doi

10.1186/s12885-019-6045-y

subject

Has Abstract

pub_date

2019-08-20 00:00:00

pages

823

issue

1

issn

1471-2407

pii

10.1186/s12885-019-6045-y

journal_volume

19

pub_type

杂志文章
  • Tumor classification and biomarker discovery based on the 5'isomiR expression level.

    abstract:BACKGROUND:The miRNA isoforms (isomiRs) have been suggested to regulate the same pathways as the canonical miRNA and play an important biological role in miRNA-mediated gene regulation. Recently, a study has demonstrated that the presence or absence of all isomiRs could efficiently discriminate amongst 32 TCGA cancer t...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5340-y

    authors: Wang S,Zheng Z,Chen P,Wu M

    更新日期:2019-02-07 00:00:00

  • High Smac/DIABLO expression is associated with early local recurrence of cervical cancer.

    abstract:BACKGROUND:In a recent pilot report, we showed that Smac/DIABLO mRNA is expressed de novo in a subset of cervical cancer patients. We have now expanded this study and analyzed Smac/DIABLO expression in the primary lesions in 109 cervical cancer patients. METHODS:We used immunohistochemistry of formalin-fixed, paraffin...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-256

    authors: Arellano-Llamas A,Garcia FJ,Perez D,Cantu D,Espinosa M,De la Garza JG,Maldonado V,Melendez-Zajgla J

    更新日期:2006-10-26 00:00:00

  • Impact of concomitant systemic treatments on toxicity and intracerebral response after stereotactic radiotherapy for brain metastases.

    abstract:BACKGROUND:The aim of this study was to determine the safety and efficacy of fractionated stereotactic radiotherapy (SRT) in combination with systemic therapies (ST) for brain metastases (BM). METHODS:Ninety-nine patients (171 BM) received SRT and concurrent ST (group 1) and 95 patients (131 BM) received SRT alone wit...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07491-z

    authors: Guénolé M,Lucia F,Bourbonne V,Dissaux G,Reygagne E,Goasduff G,Pradier O,Schick U

    更新日期:2020-10-13 00:00:00

  • A multilevel study of the determinants of area-level inequalities in colorectal cancer survival.

    abstract:BACKGROUND:In Australia, associations between geographic remoteness, socioeconomic disadvantage, and colorectal cancer (CRC) survival show that survival rates are lowest among residents of geographically remote regions and those living in disadvantaged areas. At present we know very little about the reasons for these i...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-24

    authors: Baade PD,Turrell G,Aitken JF

    更新日期:2010-01-28 00:00:00

  • Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer.

    abstract:BACKGROUND:Lymphovascular invasion (LBVI) including lymphatic (LVI) and blood (BVI) vessel invasion is a critical step in cancer metastasis. In breast cancer, the optimal detection method of LBVI remains unclear. This research aimed to compare the prognostic value of different assessments of the LVI and BVI in patients...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-676

    authors: Gujam FJ,Going JJ,Mohammed ZM,Orange C,Edwards J,McMillan DC

    更新日期:2014-09-18 00:00:00

  • A new score predicting the survival of patients with spinal cord compression from myeloma.

    abstract:BACKGROUND:This study was performed to create and validate a scoring system for the survival of patients with malignant spinal cord compression (SCC) from myeloma. METHODS:Of the entire cohort (N = 216), 108 patients were assigned to a test group and 108 patients to a validation group. In the test group, nine pre-trea...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-425

    authors: Douglas S,Schild SE,Rades D

    更新日期:2012-09-25 00:00:00

  • Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer.

    abstract:BACKGROUND:Renal cell carcinoma (RCC) is a malignant disease that demonstrates resistance to standard chemotherapeutic agents. Yet Active immunization using genetically modified dendritic cells holds promise for the adjuvant treatment of malignancies to eradicate or control residual disease. Cytokine-induced killer (CI...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章

    doi:10.1186/1471-2407-14-251

    authors: Wang D,Zhang B,Gao H,Ding G,Wu Q,Zhang J,Liao L,Chen H

    更新日期:2014-04-10 00:00:00

  • Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells.

    abstract:BACKGROUND:Photodynamic therapy (PDT) of solid cancers comprises the administration of a photosensitizer followed by illumination of the photosensitizer-replete tumor with laser light. This induces a state of local oxidative stress, culminating in the destruction of tumor tissue and microvasculature and induction of an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1994-2

    authors: Weijer R,Broekgaarden M,van Golen RF,Bulle E,Nieuwenhuis E,Jongejan A,Moerland PD,van Kampen AH,van Gulik TM,Heger M

    更新日期:2015-12-26 00:00:00

  • Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer.

    abstract:BACKGROUND:Gene-gene and gene-environment interactions involved in the metabolism of carcinogens may increase the risk of cancer. Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC). METHODS:...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-115

    authors: Fan C,Jin M,Chen K,Zhang Y,Zhang S,Liu B

    更新日期:2007-06-30 00:00:00

  • Classifying breast cancer surgery: a novel, complexity-based system for oncological, oncoplastic and reconstructive procedures, and proof of principle by analysis of 1225 operations in 1166 patients.

    abstract:BACKGROUND:One of the basic prerequisites for generating evidence-based data is the availability of classification systems. Attempts to date to classify breast cancer operations have focussed on specific problems, e.g. the avoidance of secondary corrective surgery for surgical defects, rather than taking a generic appr...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-108

    authors: Hoffmann J,Wallwiener D

    更新日期:2009-04-08 00:00:00

  • The effects of photodynamic therapy on leukemia cells mediated by KillerRed, a genetically encoded fluorescent protein photosensitizer.

    abstract:BACKGROUND:Leukemia is a cancer of blood and bone marrow cells, causing about 300,000 deaths worldwide. Photodynamic therapy (PDT) is a promising alternative for the treatment of malignant tumors. KillerRed is a genetically encoded red fluorescent protein photosensitizer (PS). In this study, we aimed to investigate the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6124-0

    authors: Yuan M,Liu C,Li J,Ma W,Yu X,Zhang P,Ji Y

    更新日期:2019-10-07 00:00:00

  • Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma.

    abstract:BACKGROUND:Programmed cell death 1 (PD1) inhibitors have recently shown promising anti-cancer effects in a number of solid tumor types. A predictive biomarker to this class of drugs has not been clearly identified; however, overexpression of the PD1 ligand (PD-L1) has shown particular promise in lung adenocarcinoma. In...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3634-5

    authors: Tessier-Cloutier B,Kalloger SE,Al-Kandari M,Milne K,Gao D,Nelson BH,Renouf DJ,Sheffield BS,Schaeffer DF

    更新日期:2017-09-05 00:00:00

  • Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression.

    abstract:OBJECTIVE:Crizotinib can target against mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK), which has been considered as a multi-targeted tyrosine kinase inhibitor (TKI). The objective of this study was to explore the efficacy of crizotinib in advanced non-small-cell lung cancer (NSCLC) with c...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5078-y

    authors: Chen RL,Zhao J,Zhang XC,Lou NN,Chen HJ,Yang X,Su J,Xie Z,Zhou Q,Tu HY,Zhong WZ,Yan HH,Guo WB,Wu YL,Yang JJ

    更新日期:2018-11-26 00:00:00

  • Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer.

    abstract:BACKGROUND:Significant progress in treatment of metastatic castration resistant prostate cancer (mCRPC) has been made. Biomarkers to tailor therapy are scarce. To facilitate decision-making we evaluated dynamic changes of alkaline phosphatase (ALP), lactate dehydrogenase (LDH) and prostate specific antigen (PSA) under ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2260-y

    authors: Mikah P,Krabbe LM,Eminaga O,Herrmann E,Papavassilis P,Hinkelammert R,Semjonow A,Schrader AJ,Boegemann M

    更新日期:2016-03-14 00:00:00

  • Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma.

    abstract:BACKGROUND:To validate the robust predictive values of tumor vascularity and hand-foot-skin reaction (HFSR) in combination treatment of transarterial chemoembolization (TACE) and sorafenib for patients with intermediate hepatocellular carcinoma (HCC), and then select the potential candidates who would survive best from...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5570-z

    authors: Wang E,Xia D,Bai W,Yuan J,Li X,Niu J,Yin Z,Xia J,Cai H,Fan D,Han G,Liu L

    更新日期:2019-04-30 00:00:00

  • NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells.

    abstract:BACKGROUND:The failure of treatment for breast cancer usually results from distant metastasis in which the epithelial-mesenchymal transition (EMT) plays a critical role. Hyperinsulinemia, the hallmark of Type 2 diabetes mellitus (T2DM), has been regarded as a key risk factor for the progression of breast cancer. Nuclea...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07107-6

    authors: Xia B,Hou L,Kang H,Chang W,Liu Y,Zhang Y,Ding Y

    更新日期:2020-07-06 00:00:00

  • P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.

    abstract:BACKGROUND:High grade gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) with a Ki67 proliferation index > 20%, include well-differentiated tumours grade 3 (NET G3) and poorly differentiated (PD) neuroendocrine carcinomas (NEC). Abnormal p53-expression is a feature of PD tumours, while expression of chromogran...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6498-z

    authors: Nielsen K,Binderup T,Langer SW,Kjaer A,Knigge P,Grøndahl V,Melchior L,Federspiel B,Knigge U

    更新日期:2020-01-10 00:00:00

  • Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer.

    abstract:BACKGROUND:The clinical implication of Ras/Raf/ERK pathway activity in breast cancer tissue and its association with response to chemotherapy is controversial. We aimed to explore the value of p90RSK phosphorylation, a downstram molecule of the pathway, in predicting chemotherapy response in breast cancer. METHODS:The...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-585

    authors: Moon HG,Yi JK,Kim HS,Lee HY,Lee KM,Yi M,Ahn S,Shin HC,Ju JH,Shin I,Han W,Noh DY

    更新日期:2012-12-10 00:00:00

  • Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial.

    abstract:BACKGROUND:Lung cancer is the most common cause of cancer related death worldwide. The majority of cases are detected at a late stage when prognosis is poor. The EarlyCDT®-Lung Test detects autoantibodies to abnormal cell surface proteins in the earliest stages of the disease which may allow tumour detection at an earl...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-017-3175-y

    authors: Sullivan FM,Farmer E,Mair FS,Treweek S,Kendrick D,Jackson C,Robertson C,Briggs A,McCowan C,Bedford L,Young B,Vedhara K,Gallant S,Littleford R,Robertson J,Sewell H,Dorward A,Sarvesvaran J,Schembri S

    更新日期:2017-03-11 00:00:00

  • Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO).

    abstract:OBJECTIVES:The present study aims to evaluate long-term side-effects and outcomes and confirm prognostic factors after stereotactic body radiotherapy (SBRT) of pulmonary lesions. This is the first work that combines the investigated data from patient charts and patient-reported outcome (PRO) up to 14 years after therap...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6635-8

    authors: Kessel KA,Grosser RCE,Kraus KM,Hoffmann H,Oechsner M,Combs SE

    更新日期:2020-05-19 00:00:00

  • Prevalence of gastrointestinal stromal tumour (GIST) in the United Kingdom at different therapeutic lines: an epidemiologic model.

    abstract:BACKGROUND:The prevalence of patients with gastrointestinal stromal tumourgst (GIST) who fail currently available treatments imatinib and sunitinib (third-line treatment-eligible GIST) is unknown, but is expected to be below an ultra-orphan disease threshold of 2/100,000 population used in England and Wales. Our study ...

    journal_title:BMC cancer

    pub_type: 杂志文章,评审

    doi:10.1186/1471-2407-14-364

    authors: Starczewska Amelio JM,Cid Ruzafa J,Desai K,Tzivelekis S,Muston D,Khalid JM,Ashman P,Maguire A

    更新日期:2014-05-24 00:00:00

  • Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial.

    abstract:BACKGROUND:There is no consensus on the therapeutic approach to ECOG 2 patients with locally advanced non-small-cell lung cancer (LA-NSCLC), despite the sizable percentage of these patients in clinical practice. This study focused on the efficacy, toxicity and the optimal chemotherapy regimen of CCRT in ECOG 2 patients...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06780-x

    authors: Bi N,Liu L,Liang J,Wu S,Chen M,Lv C,Zhao L,Shi A,Jiang W,Xu Y,Zhou Z,Wang J,Wang W,Chen D,Hui Z,Lv J,Zhang H,Feng Q,Xiao Z,Wang X,Zhang T,Yin W,Li J,He J,Wang L

    更新日期:2020-04-06 00:00:00

  • Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells.

    abstract:BACKGROUND:Cancer stem cell (CSC) hypothesis has not been well demonstrated by the lack of the most convincing evidence concerning a single cell capable of giving rise to a tumor. The scarcity in quantity and improper approaches for isolation and purification of CSCs have become the major obstacles for great developmen...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-135

    authors: Li HZ,Yi TB,Wu ZY

    更新日期:2008-05-14 00:00:00

  • Adherence to quality breast cancer survivorship care in four Canadian provinces: a CanIMPACT retrospective cohort study.

    abstract:BACKGROUND:In order to maximize later health, there are established components and guidelines for quality follow-up care of breast cancer survivors. However, adherence to quality follow-up in Canada may not be optimal, and may vary by province. We determined and compared the proportion of patients in each province who ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5882-z

    authors: McBride ML,Groome PA,Decker K,Kendell C,Jiang L,Whitehead M,Li D,Grunfeld E,CanIMPACT Team.

    更新日期:2019-07-04 00:00:00

  • Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.

    abstract:BACKGROUND:Neoadjuvant Chemotherapy (NC) including trastuzumab induces a high rate of pathological Complete Responses (pCR) in patients with locally advanced HER2-overexpressing Breast Cancer (BC), but is penalized by a severe cardiotoxicity when combined with anthracyclines. A phase II study was designed to assess whe...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-954

    authors: Miolo G,Muraro E,Martorelli D,Lombardi D,Scalone S,Spazzapan S,Massarut S,Perin T,Viel E,Comaro E,Talamini R,Bidoli E,Turchet E,Crivellari D,Dolcetti R

    更新日期:2014-12-15 00:00:00

  • Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.

    abstract:BACKGROUND:Recruitment of cofactors in the interaction of the androgen receptor (AR) and AR ligands plays a critical role in determining androgenic/antiandrogenic effects of the AR ligand on signaling, but the functions of key cofactors, including nuclear receptor coactivator (NCOA), remain poorly understood in prostat...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2378-y

    authors: Takeda K,Hara N,Nishiyama T,Tasaki M,Ishizaki F,Tomita Y

    更新日期:2016-05-25 00:00:00

  • Fast growing angiosarcoma of the right atrium after radiofrequency catheter ablation: a missed diagnosis or misdiagnosis case report.

    abstract:BACKGROUND:Primary angiosarcomas of the right atrium are extremely rare, often resulted in missed diagnosis or misdiagnosis with routine examination tools. These malignant cardiac tumors are highly aggressive with generally poor prognosis. Surgical excision is the mainstay of treatment as it is essentially not responsi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6450-2

    authors: Yu Y,Wang Q,Sun J,Zhao J,Chen S,Li Y

    更新日期:2020-01-06 00:00:00

  • Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients.

    abstract:BACKGROUND:RECQL is a number of the RecQ DNA helicase family and plays an important role in maintaining genome stability. Although several studies have reported that RECQL mutations were correlated with the susceptibility to breast cancer, the effect on prognosis in breast cancer was not yet clarified. Here, we explore...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4585-1

    authors: Xu H,Xu Y,Ouyang T,Li J,Wang T,Fan Z,Fan T,Lin B,Xie Y

    更新日期:2018-06-18 00:00:00

  • Moderate to vigorous physical activity participation associated with better quality of life among breast and colorectal cancer survivors in Korea.

    abstract:BACKGROUND:To investigate the association between physical activity (PA) and quality of life (QoL) among breast and colorectal cancer survivors in Korea. METHODS:A total of 224 cancer survivors (151 breast and 73 colorectal cancers) who completed treatments were recruited. We measured PA level with Godin Leisure-Time ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06819-z

    authors: Park JH,Lee DH,Kim SI,Kim NK,Jeon JY

    更新日期:2020-05-01 00:00:00

  • CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resecta

    abstract:BACKGROUND:Although radical surgery remains the cornerstone of cure in resectable gastric cancer, survival remains poor. Current evidence-based (neo)adjuvant strategies have shown to improve outcome, including perioperative chemotherapy, postoperative chemoradiotherapy and postoperative chemotherapy. However, these reg...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-018-4770-2

    authors: Slagter AE,Jansen EPM,van Laarhoven HWM,van Sandick JW,van Grieken NCT,Sikorska K,Cats A,Muller-Timmermans P,Hulshof MCCM,Boot H,Los M,Beerepoot LV,Peters FPJ,Hospers GAP,van Etten B,Hartgrink HH,van Berge Henegouwen MI,

    更新日期:2018-09-10 00:00:00